EP0866799A4 - Apolipoprotein e2 and treatment of alzheimer's disease - Google Patents
Apolipoprotein e2 and treatment of alzheimer's diseaseInfo
- Publication number
- EP0866799A4 EP0866799A4 EP96937887A EP96937887A EP0866799A4 EP 0866799 A4 EP0866799 A4 EP 0866799A4 EP 96937887 A EP96937887 A EP 96937887A EP 96937887 A EP96937887 A EP 96937887A EP 0866799 A4 EP0866799 A4 EP 0866799A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- apolipoprotein
- alzheimer
- disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55172295A | 1995-11-01 | 1995-11-01 | |
US551722 | 1995-11-01 | ||
PCT/US1996/017629 WO1997016458A1 (en) | 1995-11-01 | 1996-10-31 | Apolipoprotein e2 and treatment of alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0866799A1 EP0866799A1 (en) | 1998-09-30 |
EP0866799A4 true EP0866799A4 (en) | 2000-08-23 |
Family
ID=24202413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96937887A Withdrawn EP0866799A4 (en) | 1995-11-01 | 1996-10-31 | Apolipoprotein e2 and treatment of alzheimer's disease |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0866799A4 (en) |
JP (1) | JP2000500332A (en) |
AU (1) | AU720446B2 (en) |
BR (1) | BR9611329A (en) |
CA (1) | CA2236274A1 (en) |
MX (1) | MX9803422A (en) |
WO (1) | WO1997016458A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000023587A2 (en) * | 1998-10-16 | 2000-04-27 | Introgene B.V. | Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
CA2349229A1 (en) * | 1998-11-25 | 2000-06-02 | Scios Inc. | Prevention and treatment of amyloid-associated disorders |
CN1315402A (en) * | 2000-03-28 | 2001-10-03 | 上海博德基因开发有限公司 | Polypeptide-human amyloid precursor protein bindin 14 and polynucleotide for coding it |
CN1315439A (en) * | 2000-03-29 | 2001-10-03 | 上海博德基因开发有限公司 | Polypeptide-human amyloid precursor protein bindin 9 and polynucleotide for coding it |
WO2005032596A1 (en) * | 2003-09-26 | 2005-04-14 | Eli Lilly And Company | Lentiviral apoe2 gene therapy |
EP1991252A2 (en) * | 2006-02-21 | 2008-11-19 | Oklahoma Medical Research Foundation | Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor |
WO2010020822A1 (en) * | 2008-08-19 | 2010-02-25 | University Of Patras | Therapy for apolipoprotein-induced hypertriglyceridemia |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002670A1 (en) * | 1994-07-20 | 1996-02-01 | Smithkline Beecham Plc | Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU587989B2 (en) * | 1984-10-16 | 1989-09-07 | Mitsubishi Chemical Corporation | DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins |
-
1996
- 1996-10-31 WO PCT/US1996/017629 patent/WO1997016458A1/en not_active Application Discontinuation
- 1996-10-31 CA CA 2236274 patent/CA2236274A1/en not_active Abandoned
- 1996-10-31 AU AU75526/96A patent/AU720446B2/en not_active Ceased
- 1996-10-31 JP JP9517597A patent/JP2000500332A/en not_active Ceased
- 1996-10-31 EP EP96937887A patent/EP0866799A4/en not_active Withdrawn
- 1996-10-31 BR BR9611329-4A patent/BR9611329A/en not_active Application Discontinuation
-
1998
- 1998-04-30 MX MX9803422A patent/MX9803422A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002670A1 (en) * | 1994-07-20 | 1996-02-01 | Smithkline Beecham Plc | Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases |
Non-Patent Citations (6)
Title |
---|
BIOLOGICAL ABSTRACTS, vol. 1994, 1994, Philadelphia, PA, US; abstract no. 345993, E H CORDER ET AL.: "Protective effect of apolioprotein E type 2 allele for late onset Alzheimer disease" XP002140639 * |
C S HANLON & D C RUBINSZTEIN: "Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans.", ATHEROSCLEROSIS, vol. 112, no. 1, 6 January 1995 (1995-01-06), AMSTERDAM, NL, pages 85 - 90, XP002005036, ISSN: 0021-9150, DOI: doi:10.1016/0021-9150(94)05402-5 * |
C TALBOT ET AL.: "Protection against Alzheimer's disease with apoE epsilon 2", LANCET THE., vol. 343, 4 June 1994 (1994-06-04), LANCET LIMITED. LONDON., GB, pages 1432 - 1433, XP002140637, ISSN: 0140-6736 * |
File Medline, abstract 95290021, 1995 * |
NATURE GENETICS., vol. 7, no. 2, 1994, pages 180 - 184, ISSN: 1061-4036 * |
See also references of WO9716458A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997016458A1 (en) | 1997-05-09 |
AU720446B2 (en) | 2000-06-01 |
EP0866799A1 (en) | 1998-09-30 |
AU7552696A (en) | 1997-05-22 |
CA2236274A1 (en) | 1997-05-09 |
JP2000500332A (en) | 2000-01-18 |
MX9803422A (en) | 1998-11-29 |
BR9611329A (en) | 1999-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2830097A (en) | Therapeutic method for treatment of alzheimer's disease | |
IL112050A0 (en) | Methods of inhibiting alzheimer's disease | |
AU7397094A (en) | Prevention and treatment of alzheimer's disease | |
EP0735870A4 (en) | Use of pla 2? inhibitors as treatment for alzheimer's disease | |
AU4650096A (en) | Neural thread protein gene expression and detection of alzheimer's disease | |
HU9302551D0 (en) | Compounds having effect against hypoglycemia and alzheimer's disease | |
EP1043991A4 (en) | Treatment for alzheimer's disease | |
EP0746322A4 (en) | Treatment of alzheimer's disease and modulation of immune system with delta5-androstenes | |
GB9316727D0 (en) | Models of alzheimers's disease | |
IL105216A0 (en) | Method and kit for the diagnosis of alzheimer's disease | |
AU3279395A (en) | Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes | |
ZA962846B (en) | Treatment of traveller's diarrhea | |
NO20001869D0 (en) | Procedures for the treatment of Alzheimer's disease | |
IL117695A0 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
EP0866799A4 (en) | Apolipoprotein e2 and treatment of alzheimer's disease | |
EP0842189A4 (en) | Early onset alzheimer's disease gene and gene products | |
GB9602162D0 (en) | Treatment of waste | |
EP0833641A4 (en) | Treatment and prevention of prostatic disease | |
EP0862442A4 (en) | Methods for diagnosis and treatment of bloom's syndrome | |
GB9516572D0 (en) | Prevention and/or treatment of disease | |
GB9709416D0 (en) | Methods for treatment of alzheimer's disease using azaspiranes | |
GB9323826D0 (en) | Diagnosis of alzheimer's disease | |
ZA961060B (en) | Treatment of titanium-containing material | |
GB9517266D0 (en) | Diagnosis of alzheimer's disease | |
AU8700998A (en) | Use of Apolipoprotein polymorphism E in the treatment of Alzheimer's disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980529 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000706 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20010621 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020903 |